Brief: HBM Portfolio Company Arrakis Enters Into Collaboration, License Agreement With Roche

HBM Healthcare Investments AG

08/04/2020 17:28

April 8 (Reuters) - Hbm Healthcare Investments Ag  HBMN.S :
    * HBM PORTFOLIO COMPANY ARRAKIS THERAPEUTICS ENTERS
STRATEGIC
COLLABORATION AND LICENSE AGREEMENT WITH ROCHE
    * ARRAKIS WILL RECEIVE AN UPFRONT PAYMENT OF USD 190 MILLION
IN
CASH
    * HBM HEALTHCARE - ARRAKIS,  ROCHE COLLABORATE FOR DISCOVERY
OF
RSM DRUGS AGAINST BROAD SET OF TARGETS ACROSS ALL OF ROCHE'S
RESEARCH AND DEVELOPMENT AREAS
    * TRANSACTION HAS NO IMMEDIATE IMPACT ON VALUATION OF OUR
INVESTMENT
    * AGGREGATE POTENTIAL VALUE OF FUTURE PAYMENTS TO ARRAKIS
EXCEEDS
SEVERAL BILLION DOLLARS

Source text for Eikon:  ID:nTEN934zna 
Further company coverage:  HBMN.S 

 ((Reuters.Briefs@thomsonreuters.com;))